English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Merck
Carol Ostrow
| May 16, 2018
FDA accepts two new drug applications for Merck HIV-1 therapy
Marian Johns
| Jan 17, 2018
FDA approves Lynparza as first PARP Inhibitor for treating metastatic breast cancer
Carol Ostrow
| Jan 7, 2018
Merck, Pfizer Type 2 diabetes treatments gain FDA approval
Carol Ostrow
| Oct 15, 2017
Merck KGaA aims raise awareness, boost support for unpaid caregivers
Carol Ostrow
| Oct 1, 2017
Merck to host meeting on third-quarter performance
Russell Boniface
| Sep 13, 2017
Merck's Keytruda wins European approval as bladder cancer treatment
Robert Hadley
| Jun 16, 2017
Merck’s Keytruda shown effective in treating aggressive form of breast cancer
Tabitha Fleming
| Jun 2, 2017
Merck's Keytruda approved for treating Hodgkin's lymphoma in Europe
Trending
+
Technology/Innovation
Patient Daily
| May 8, 2025
Medfluence attends 2025 Annual Clinical Assembly as only strategic marketing firm
+
Technology/Innovation
Patient Daily
| May 7, 2025
OTO Forum 2025 highlights innovation in ENT
+
Pharmaceuticals
Patient Daily
| May 8, 2025
Pacific Research Institute CEO: Hospitals are leveraging 340B's 'perverse incentives to enrich themselves'
+
Regulatory
Patient Daily
| May 12, 2025
Turning Point USA founder: 'Big pharma’s lobbying of Washington DC has long allowed them to price gouge Americans'
1
2
»
Last »
